ArticleEuropean review of aging and physical activity : official journal of the European Group for Research into Elderly and Physical Activity2023
Grip strength cut-points from the Swiss DO-HEALTH population.
Article in European review of aging and physical activity : official journal of the European Group for Research into Elderly and Physical Activity, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT01745263 (Vitamin D3 - Omega3 - Home Exercise - Healthy Ageing and Longevity Trial), which is not on this map. Cited by 10 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Vitamin D3 - Omega3 - Home Exercise - Healthy Ageing and Longevity Trial (Acronym: DO-HEALTH)
Who cites it
10 citing papers in PubMed, 12 citations in OpenAlex.
- Effects of vitamin D3, omega-3 fatty acids and a simple home exercise program on change in physical activity among generally healthy and active older adults: The 3-year DO-HEALTH trial.The journal of nutrition, health & aging · 2025Trial
- Effect of vitamin D, omega-3 supplementation, or a home exercise program on muscle mass and sarcopenia: DO-HEALTH trial.Journal of the American Geriatrics Society · 2025Trial
- Article
- Sarcopenia in Hospitalized Older Adults: A Cross-Sectional Study Comparing Diagnostic Thresholds and Handgrip Strength Measurement Tools.Geriatrics (Basel, Switzerland) · 2026Article
- Nutrition Focused Physical Examination Components Specific to Older Adults: A Modified Delphi Study.Journal of human nutrition and dietetics : the official journal of the British Dietetic Association · 2025Article
- Cross-sectional assessment of the Tinetti performance-oriented mobility tool for screening physical frailty syndrome in older adults.BMC geriatrics · 2025Article
- Malnutrition and sarcopenia in inpatient rehabilitation: prevalence and associations with changes in bodyweight, muscle strength, and functional independence.Journal of rehabilitation medicine · 2025Observational
- Two Methods of Handgrip Strength Assessment in Sarcopenia Evaluation: Associations with in-Hospital Mortality in Older Adults.Clinical interventions in aging · 2025Article
- Frailty assessment in geriatric trauma patients: comparing the predictive value of the full and a condensed version of the Fried frailty phenotype.BMC geriatrics · 2024Article
- Calf circumference as a surrogate indicator for detecting low muscle mass in hospitalized geriatric patients.Aging clinical and experimental research · 2024Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors at 7 institutions in 5 countries.
Funding
Abstract
backgroundWhile grip strength (GS) is commonly assessed using a Dynamometer, the Martin Vigorimeter was proposed as an alternative method especially in older adults. However, its reference values for Swiss older adults are missing. We therefore aimed to derive sex- and age-specific GS cut-points for the dominant and non-dominant hand (DH; NDH) using the Martin Vigorimeter. Additionally, we aimed to identify clinically relevant weakness and assess convergent validity with key markers of physical function and sarcopenia in generally healthy Swiss older adults.
methodsThis cross-sectional analysis includes baseline data from Swiss participants enrolled in DO-HEALTH, a 3-year randomized controlled trial in community-dwelling adults age 70 + . For both DH and NDH, 4 different definitions of weakness to derive GS cut-points by sex and age category (≤ 75 vs. > 75 years) were used: i) GS below the median of the 1
resultsIn total, 976 participants had available GS at the DH (mean age 75.2, 62% women). According to the 4 weakness definitions, GS cut-points at the DH ranged from 29-42 and 25-39 kPa in younger and older women respectively, and from 51-69 and 31-50 kPa in younger and older men respectively. Overall, weakness prevalence ranged from 2.0% to 19.3%. Definitions of weakness using the median and the upper limit of the 1
conclusionsIn generally healthy Swiss older adults, weakness defined by the median or the upper limit of the 1
trial registrationClinicalTrials.gov Identifier: NCT01745263.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.